47 related articles for article (PubMed ID: 22394132)
1. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues.
Papachristou DJ; Sklirou E; Corradi D; Grassani C; Kontogeorgakos V; Rao UN
Histopathology; 2012 May; 60(6B):E28-36. PubMed ID: 22394132
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Rhabdomyoblastic Tumor: From a Nebulous Smooth Muscle Neoplasm to a Novel Skeletal Muscle Tumor Subtype.
Michal M
Surg Pathol Clin; 2024 Mar; 17(1):65-76. PubMed ID: 38278608
[TBL] [Abstract][Full Text] [Related]
4. From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.
Pantazopoulou VI; Georgiou S; Kakoulidis P; Giannakopoulou SN; Tseleni S; Stravopodis DJ; Anastasiadou E
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503341
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.
Mironova N; Vlassov V
Front Pharmacol; 2019; 10():1019. PubMed ID: 31572192
[TBL] [Abstract][Full Text] [Related]
6. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer.
Casey MC; Prakash A; Holian E; McGuire A; Kalinina O; Shalaby A; Curran C; Webber M; Callagy G; Bourke E; Kerin MJ; Brown JA
BMC Cancer; 2019 Jul; 19(1):712. PubMed ID: 31324173
[TBL] [Abstract][Full Text] [Related]
7. Quantifying Tip60 (Kat5) stratifies breast cancer.
McGuire A; Casey MC; Shalaby A; Kalinina O; Curran C; Webber M; Callagy G; Holian E; Bourke E; Kerin MJ; Brown JAL
Sci Rep; 2019 Mar; 9(1):3819. PubMed ID: 30846725
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder.
Rabien A; Ratert N; Högner A; Erbersdobler A; Jung K; Ecke TH; Kilic E
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857476
[TBL] [Abstract][Full Text] [Related]
9.
Jeong W; Bae H; Lim W; Song G
J Anim Sci; 2017 Nov; 95(11):4857-4868. PubMed ID: 29293730
[TBL] [Abstract][Full Text] [Related]
10. Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma.
Kim MN; Kim JO; Lee SM; Park H; Lee JH; Rim KS; Hwang SG; Kim NK
PLoS One; 2016; 11(9):e0162279. PubMed ID: 27611467
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.
Zhang H; Hou Y; Xu L; Zeng Z; Wen S; Du YE; Sun K; Yin J; Lang L; Tang X; Liu M
Dig Dis Sci; 2016 Apr; 61(4):1080-90. PubMed ID: 26694172
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of microRNA biogenesis machinery in cancer.
Hata A; Kashima R
Crit Rev Biochem Mol Biol; 2016; 51(3):121-34. PubMed ID: 26628006
[TBL] [Abstract][Full Text] [Related]
13. Argonaute 2: A Novel Rising Star in Cancer Research.
Ye Z; Jin H; Qian Q
J Cancer; 2015; 6(9):877-82. PubMed ID: 26284139
[TBL] [Abstract][Full Text] [Related]
14. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
[TBL] [Abstract][Full Text] [Related]
15. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA biogenesis pathways in cancer.
Lin S; Gregory RI
Nat Rev Cancer; 2015 Jun; 15(6):321-33. PubMed ID: 25998712
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of dicer and mir-155 expression in liposarcoma.
Vincenzi B; Iuliani M; Zoccoli A; Pantano F; Fioramonti M; De Lisi D; Frezza AM; Rabitti C; Perrone G; Onetti Muda A; Russo A; Giordano A; Santini D; Dei Tos AP; Tonini G
Oncotarget; 2015 Apr; 6(12):10586-91. PubMed ID: 25888631
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Machinery Genes as Novel Biomarkers for Cancer.
Huang JT; Wang J; Srivastava V; Sen S; Liu SM
Front Oncol; 2014; 4():113. PubMed ID: 24904827
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of deregulated dicer expression in breast cancer.
Caffrey E; Ingoldsby H; Wall D; Webber M; Dinneen K; Murillo LS; Inderhaug C; Newell J; Gupta S; Callagy G
PLoS One; 2013; 8(12):e83724. PubMed ID: 24386264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
